TRU:NYSETransUnion Analysis
Data as of 2026-05-27 - not real-time
$71.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its 20‑day and 50‑day SMAs, with a bearish trend and decreasing volume, while the 30‑day volatility sits near 37% and beta exceeds 1.2, indicating heightened price swings. Valuation metrics show the market price (~$71) above the DCF‑derived fair value (~$64) and a trailing P/E (~20) that exceeds the industry average, suggesting the stock is currently overvalued.
Fundamental outlook: Despite the pricing pressure, TransUnion delivers solid revenue growth (~13% YoY), high gross margins (~59%), and a low payout ratio (~13%), supporting dividend sustainability. Forward earnings expectations compress the P/E to around 13, analysts maintain a "Buy" consensus with a target near $90, and a recent partnership with Google highlights growth potential in data‑driven marketing solutions.
Fundamental outlook: Despite the pricing pressure, TransUnion delivers solid revenue growth (~13% YoY), high gross margins (~59%), and a low payout ratio (~13%), supporting dividend sustainability. Forward earnings expectations compress the P/E to around 13, analysts maintain a "Buy" consensus with a target near $90, and a recent partnership with Google highlights growth potential in data‑driven marketing solutions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical positioning (price below SMAs, decreasing volume)
- Current price above fair value
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E discount to industry peers
- Strong revenue growth and high operating margins
- Analyst consensus buy with upside potential toward $90 target
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic partnership with Google expanding data solutions
- Sustainable dividend backed by robust cash flow
- Recurring, high‑margin credit and analytics business model
Key Metrics & Analysis
Financial Health
Revenue Growth13.70%
Profit Margin14.90%
P/E Ratio19.7
ROE15.25%
ROA4.65%
Debt/Equity115.67
P/B Ratio3.1
Op. Cash Flow$1.0B
Free Cash Flow$749.8M
Industry P/E16.7
Technical Analysis
TrendBearish
RSI53.3
Support$64.51
Resistance$73.62
MA 20$69.43
MA 50$70.59
MA 200$79.46
MACDBullish
VolumeDecreasing
Fear & Greed Index91.11
Valuation
Fair Value$64.04
Target Price$90.19
Upside/Downside26.68%
GradeOvervalued
TypeBlend
Dividend Yield0.71%
Risk Assessment
Beta1.25
Volatility36.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.